Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report

Cases of late onset neutropenia (LON) after rituximab therapy have been documented, but few cases have been documented of early onset neutropenia (EON). We present a case report of a patient with mantle cell lymphoma who presented with EON, only 6 days after initiation of rituximab therapy, notable...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelson, Blessie Elizabeth, Tipton, Shelby, Venkatesan, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256914/
https://www.ncbi.nlm.nih.gov/pubmed/34267851
http://dx.doi.org/10.14740/jh814
Descripción
Sumario:Cases of late onset neutropenia (LON) after rituximab therapy have been documented, but few cases have been documented of early onset neutropenia (EON). We present a case report of a patient with mantle cell lymphoma who presented with EON, only 6 days after initiation of rituximab therapy, notable for the shortest duration to EON ever reported in literature. Throughout this paper, we explore the potential pathogenesis and incidence of EON with the help of our unique case.

Ejemplares similares